OA

Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States

Retrieved on: 
Wednesday, September 6, 2023
General Health, Health, Medical Devices, Surgeon, University, Terminal, Orthopedic surgery, Oregon Health & Science University, Quality of life, Arthropathy, Hamstring, Cartilage, Trial of the century, Pain, OA, Hospital for Special Surgery, Rehabilitation, Motion, Walking, Standard of care, Patient, Physician, School, SUNY Downstate Health Sciences University, HSS, ISA, Hospital, Ageing, Meniscus, FDA, Chronic pain, Osteoarthritis, University of Virginia, Female, Knee, Dentistry, DRS

Until the MISHA Knee System became available in April 2023, physicians and many patients had limited treatment options when conservative treatments failed.

Key Points: 
  • Until the MISHA Knee System became available in April 2023, physicians and many patients had limited treatment options when conservative treatments failed.
  • Prior to the MISHA Knee System being available, I had no good options for this patient.
  • For these patients, total knee replacement is a reluctant option, as it is an end-stage treatment for end-stage disease.
  • OA patients without end-stage disease seek options that preserve their knee, activity level, and quality of life.

Clarivate Annual G20 Scorecard Analyzes Global Research Performance Trends Across G20 Nations

Retrieved on: 
Wednesday, August 30, 2023
Collaboration, Partnership, ISI, Social, Clarivate, Specialization, CLVT, Education, Senior, Intelligence, Asian literature, Humanities, Research, Medicine, Government, Organization, CNCI, OA, GDP, Patent, Korea, Non-governmental organization, G20, United Kingdom, Knowledge, NYSE, Female, Institute for Scientific Information, Management, Creative industries, Pharmaceutical industry, Arms industry, EU

LONDON, Aug. 30, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual G20 scorecard, which for the first time examines the research performance of each G20 member through dynamic, interactive data visualizations. It offers a detailed and insightful overview of research trends, collaboration patterns and scientific impact, showcasing the contributions of the 19 G20 member nations* to the global research landscape.

Key Points: 
  • It offers a detailed and insightful overview of research trends, collaboration patterns and scientific impact, showcasing the contributions of the 19 G20 member nations* to the global research landscape.
  • The G20 scorecard presents an exceptional vantage point on the strengths and challenges of each G20 nation's research ecosystem.
  • Key findings in the 2023 G20 scorecard include:
    Mainland China accrued three times as many patents as any other individual G20 member in 2021.
  • The annual G20 scorecard – Research performance 2023 is available to explore on the Institute for Scientific Information's page on Clarivate.com, with a freely downloadable executive summary highlighting key findings.

Clarivate Annual G20 Scorecard Analyzes Global Research Performance Trends Across G20 Nations

Retrieved on: 
Wednesday, August 30, 2023
Collaboration, Partnership, ISI, Social, Clarivate, Specialization, CLVT, Education, Senior, Intelligence, Asian literature, Humanities, Research, Medicine, Government, Organization, CNCI, OA, GDP, Patent, Korea, Non-governmental organization, G20, United Kingdom, Knowledge, NYSE, Female, Institute for Scientific Information, Management, Creative industries, Pharmaceutical industry, Arms industry, EU

LONDON, Aug. 30, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual G20 scorecard, which for the first time examines the research performance of each G20 member through dynamic, interactive data visualizations. It offers a detailed and insightful overview of research trends, collaboration patterns and scientific impact, showcasing the contributions of the 19 G20 member nations* to the global research landscape.

Key Points: 
  • It offers a detailed and insightful overview of research trends, collaboration patterns and scientific impact, showcasing the contributions of the 19 G20 member nations* to the global research landscape.
  • The G20 scorecard presents an exceptional vantage point on the strengths and challenges of each G20 nation's research ecosystem.
  • Key findings in the 2023 G20 scorecard include:
    Mainland China accrued three times as many patents as any other individual G20 member in 2021.
  • The annual G20 scorecard – Research performance 2023 is available to explore on the Institute for Scientific Information's page on Clarivate.com, with a freely downloadable executive summary highlighting key findings.

Zoetis Announces Second Quarter 2023 Results

Retrieved on: 
Tuesday, August 8, 2023
Veterinary, Pharmaceutical, Pets, General Health, Health, Infectious Diseases, Consumer, Other Health, Vaccine, Mab, International, Animal, Poultry, Sustainability reporting, Veterinarian, Rotation, Farmer, Disclosure, Human, Livestock, Atopic dermatitis, Inflammation, Dermatitis, OA, Dermatology, Acquisition, Inc., MFA Oil, Community, Dog, Itch, European, Cattle, Growth, Pain management, ESG, Webcast, NYSE, Cat, Renewable energy, Fine chemical, Cryptocurrency, EU, Diagnosis, Zoetis

(NYSE:ZTS) today reported its financial results for the second quarter of 2023 and updated its guidance for full year 2023.

Key Points: 
  • (NYSE:ZTS) today reported its financial results for the second quarter of 2023 and updated its guidance for full year 2023.
  • The company reported revenue of $2.2 billion for the second quarter of 2023, an increase of 6% compared with the second quarter of 2022.
  • On an operational1 basis, revenue for the second quarter of 2023 increased 9% compared with the second quarter of 2022, excluding the impact of foreign currency.
  • Zoetis will host a webcast and conference call at 8:30 a.m. (ET) today, during which company executives will review second quarter 2023 results, discuss financial guidance and respond to questions from financial analysts.

OpenAccess Color Team Garners Annual Si2 Power of Partnerships Award

Retrieved on: 
Tuesday, July 25, 2023
Software, Networks, Internet, Electronic Design Automation, Technology, Semiconductor, Security, Engineering, Nanotechnology, Automotive Manufacturing, Other Technology, Aerospace, Manufacturing, Si2, Printer Working Group, EDA, IC, Defense Production Act of 1950, Microsoft, National Cooperative Research and Production Act, OpenAccess, Compact, OA, Silicon, Working Group, Global Smoke-Free Partnership Award, Intel, Silicon Integration Initiative, Information technology

Technologists from Intel and Microsoft are 2023 winners of the Silicon Integration Initiative Power of Partnerships Award, presented annually to the Si2 volunteer team with the most significant contributions to the electronic design automation industry.

Key Points: 
  • Technologists from Intel and Microsoft are 2023 winners of the Silicon Integration Initiative Power of Partnerships Award, presented annually to the Si2 volunteer team with the most significant contributions to the electronic design automation industry.
  • The Si2 OpenAccess Multi-Patterning Technology (oaxColor) Working Group, led by Benjamin Hoefer of Intel, won the award for developing oaxColor, a managed extension to the OpenAccess API.
  • OpenAccess is one of the most widely used open-reference databases for IC design.
  • Marshall Tiner, Si2 senior director of OpenAccess, said, “The lack of multipattern technology support had impeded the further expansion of OA interoperability in this area.

CCC Announces Enhancement to Consortia Processing of Open Access Agreements in its Innovative RightsLink for Scientific Communications Workflow Solution

Retrieved on: 
Tuesday, July 18, 2023
University, Data Management, Education, Technology, Professional Services, Publishing, Communications, Research, Software, Legal, Science, Intelligence, Learning, Association of Learned and Professional Society Publishers, Metadata, ESAC, Society, Society for Scholarly Publishing, SSP, International Association, London, Open access, CCC, OA, Outline, Rare-earth magnet, STM, Scientific community, APC, Open Access Scholarly Publishing Association, Copyright Clearance Center, London Book Fair, OASPA, ALPSP

CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC).

Key Points: 
  • CCC , the leading provider of Open Access (OA) workflow solutions, announces an enhancement to the processing of OA Agreements for university library consortia in its innovative scholarly communications workflow solution for the OA community, RightsLink for Scientific Communications (RLSC).
  • The latest RLSC release facilitates automated delivery of the ESAC Articles List to relevant administrators.
  • Scheduled delivery of this critical data enables publishers to communicate with institutional customers and other stakeholders more easily and to monitor agreement performance more efficiently.
  • It is the most widely-adopted, community-led market solution that simplifies OA agreement administration for publishers, funders, institutions, and authors.

Angry@Arthritis Launches 1st Global Osteoarthritis Clinical Trial Locator

Retrieved on: 
Tuesday, July 18, 2023
Health, FDA, Stem Cells, Physical Therapy, Clinical Trials, Research, Science, NITRO, Federation, Advancement Project, Anger, Arthritis Foundation, Regeneration, Clinical trial, Arthritis, Spotify, Doctor of Philosophy, Mix, ARPA, Pain, OA, Patient, Map, Chart, Joint, Disease, Geography, Furniture, Pharmaceutical industry, Osteoarthritis

Angry@Arthritis, a nonprofit focused on attacking and eliminating Osteoarthritis (OA), today announced OA Fix ~Trials in the Mix, the first global OA developmental treatment analysis and clinical trial locator – https://www.angryarthritis.org/oa-fix-trials-in-the-mix/ .

Key Points: 
  • Angry@Arthritis, a nonprofit focused on attacking and eliminating Osteoarthritis (OA), today announced OA Fix ~Trials in the Mix, the first global OA developmental treatment analysis and clinical trial locator – https://www.angryarthritis.org/oa-fix-trials-in-the-mix/ .
  • Designed to empower patients and developers with new insights, the free interactive chart shows viable OA treatments in development, joints where those treatments apply, associated procedure, position in the clinical trial process, and geography (U.S. or overseas).
  • Developed by Angry@Arthritis, the chart is the product of 18 months of due diligence, including extensive research and face-to-face meetings with global research and clinical OA experts.
  • In May, the Advanced Project Research Agency for Health (ARPA-H) announced its Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program to cure OA.

CCC to Host Interactive Webcast on ‘The State of Scholarly Metadata in 2023: Industry Insights From Around the Globe’

Retrieved on: 
Thursday, July 13, 2023
Data Management, Technology, Professional Services, Publishing, Communications, Other Science, Other Technology, Research, Software, Legal, Science, Database, Learning, Metadata, Association of Learned and Professional Society Publishers, Society, Society for Scholarly Publishing, University, Health, SSP, Culture, ISO, University of Vienna, International Association, ISNI, ORCID, Doctor of Philosophy, London, Open access, ID, Government, Information, CCC, OA, FAIR, Acquisition, Pids, STM, Scientific community, Knowledge, APC, Ecosystem, Unilog Content Solutions, Open Access Scholarly Publishing Association, Copyright Clearance Center, Town hall, London Book Fair, VIP, Management, OASPA, Ethics, Access, ALPSP

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will present an interactive webcast – The State of Scholarly Metadata in 2023: Industry Insights From Around the Globe – on Thursday, 20 July at 11AM EDT/4 PM BST.

Key Points: 
  • CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will present an interactive webcast – The State of Scholarly Metadata in 2023: Industry Insights From Around the Globe – on Thursday, 20 July at 11AM EDT/4 PM BST.
  • A VIP panel of industry experts will discuss the importance of prioritizing metadata management for the open scholarly community and explore pragmatic solutions for future publishing workflows.
  • The session is moderated by Deni Auclair , Media Growth Strategies, and Jamie Carmichael , Senior Director, Information and Content Solutions, CCC.
  • “When it comes to moving successful Open Access initiatives forward, high-quality scholarly metadata is crucial,” said Emily Sheahan, Vice President & Managing Director, CCC.

AIP Publishing Launches Subscribe to Open Pilot in Two Flagship Journals

Retrieved on: 
Thursday, July 6, 2023
Science, Communication, AIP, Librarian, Subscription business model, Research, Open access, World Bank, OA, American Institute of Physics, Journal, Publication, Publishing, Gold, Risk, Physics, Self-archiving, Read, S2O

MELVILLE, N.Y., July 6, 2023 /PRNewswire/ -- AIP Publishing is excited to announce the launch of a pilot program for the Subscribe to Open (S2O) model in two of its most esteemed journals, Physics of Plasmas and Journal of Applied Physics.

Key Points: 
  • MELVILLE, N.Y., July 6, 2023 /PRNewswire/ -- AIP Publishing is excited to announce the launch of a pilot program for the Subscribe to Open (S2O) model in two of its most esteemed journals, Physics of Plasmas and Journal of Applied Physics.
  • The pilot, which reflects AIP Publishing's commitment to equity, accessibility, and open science, is set to launch in 2024.
  • "As we continue to navigate our transition to open science, it's incumbent upon AIP Publishing to explore groundbreaking options like S2O," said Penelope Lewis, Chief Publishing Officer at AIP Publishing.
  • For more information on the S2O model and its implementation at AIP Publishing, please click here.

NFL Alumni Health and Paradigm anticipate touchdown for unmet osteoarthritis pain

Retrieved on: 
Tuesday, June 27, 2023
Paradigm, Osteoarthritis, NFL, Super Bowl, Hip, Arthritis, 2021 NFL Draft, Stiffness, Calendar, ASX, National Football League Alumni, Research, Pain, OA, PAR, Laurel, Patient, Risk, National Football League Draft, System, Knee, Disease

NFL Alumni Health aimed to provide their community of players, former players, and their families with dedicated information about predominant medical issues affecting this group.

Key Points: 
  • NFL Alumni Health aimed to provide their community of players, former players, and their families with dedicated information about predominant medical issues affecting this group.
  • The two-hour health symposium was chaired by two-time Super Bowl winner and Co-President of NFL Alumni Health, Billy Davis.
  • NFL Alumni Health hopes to raise awareness about the importance of addressing osteoarthritis in NFL players and the wider community.
  • In addition to osteoarthritis, Dr Marc Taormina, who works closely with the NFL Alumni in Kansas City, discussed gastrointestinal challenges faced by current and former NFL players.